JP Patent

JP4846151B2 — 骨髄もしくは血液幹細胞の移植前の患者のコンディショニングのためのトレオスルファンの使用

Assigned to Medac Gesellschaft fuer Klinische Spezialpraeparate mbH · Expires 2011-12-28 · 14y expired

What this patent protects

Patent listed against Trecondi.

Drugs covered by this patent

Trecondi (TREOSULFAN) · Medexus

Patent Metadata

Patent number: JP4846151B2
Jurisdiction: JP
Classification: —
Expires: 2011-12-28
Drug substance claim: No
Drug product claim: No
Assignee: Medac Gesellschaft fuer Klinische Spezialpraeparate mbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.